The comparison glycemic control in two group patient treated with insulin alone and insulin plus sulfunyl urea

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201204229536N1

Enrollment

Registered

2012-04-30

Start date

2012-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type II Diabetes. Type II Diabetes

Interventions

Intervention 1: Intervention group 1: Insulin 0.2 u/kg /day and sulfonylurea whit previous dose. Intervention 2: Intervention group 2: Insulin 0.3 u/kg /day.

Treatment - Drugs

Intervention group 1: Insulin 0.2 u/kg /day and sulfonylurea whit previous dose

Intervention group 2: Insulin 0.3 u/kg /day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: history of diabetes mellitus; secondary failure ( HbA1C>7.5 FBS>140 ) and treating with sulfonylurea. Exclusion criteria: sever heart failure; renal failure ( cr>2.5); artherial failure; take corticosteroide; Diabetic ketoacidosis; liver failure; hypotension and critical illness.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood glucose. Timepoint: 4 times a day. Method of measurement: Glucometer.;Weight gain. Timepoint: 3 months after intervention. Method of measurement: Digital scale.;Hypoglycemic event. Timepoint: 3 months after intervention. Method of measurement: Glucometer.	—

Secondary

Measure	Time frame
Dosage of the insulin. Timepoint: 4 times a day. Method of measurement: With insulin syringes.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeedeh pourmohammad

Metabolic Diseases Research Center, Qazvin University of Medical Sciences

spourmohammad@qums.ac.ir+98 28 1336 0084

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026